Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

      Share Article
      share to

      NEW BRUNSWICK, N.J., Aug. 9, 2022 -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).

      This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      The audio webcast replay will be available approximately 48-hrs after the webcast.

      Media Contacts:
      Jake Sargent
      (732) 524-1090

      Investor Contacts:
      Lisa Romanko
      (732) 524-2034

      Sarah Wood
      (732) 524-2617

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.